Envestnet Portfolio Solutions Inc. Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Envestnet Portfolio Solutions Inc. acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,127 shares of the exchange traded fund’s stock, valued at approximately $290,000.

A number of other institutional investors and hedge funds have also bought and sold shares of XBI. ICA Group Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $27,000. Scarborough Advisors LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $32,000. BOCHK Asset Management Ltd acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $36,000. ORG Partners LLC acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth about $40,000. Finally, Vima LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $45,000.

SPDR S&P Biotech ETF Trading Down 1.6 %

Shares of SPDR S&P Biotech ETF stock opened at $100.14 on Friday. The business has a 50-day moving average price of $95.78 and a two-hundred day moving average price of $93.05. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The company has a market cap of $7.63 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.